Bildkälla: Stockfoto

Bonesupport Q3: Keeps on beating our estimates - Redeye

Redeye reiterates its SEK 132 base case for BONESUPPORT following the Q3 report. Our confidence in the potential for the CERAMENT platform, particularly in the US with CERAMENT G, is strengthened after seeing continuous strong growth in the US with an ever-increasing solid foundation.

Redeye reiterates its SEK 132 base case for BONESUPPORT following the Q3 report. Our confidence in the potential for the CERAMENT platform, particularly in the US with CERAMENT G, is strengthened after seeing continuous strong growth in the US with an ever-increasing solid foundation.
Börsvärldens nyhetsbrev
ANNONSER